{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T01:50:11Z","timestamp":1791510611938,"version":"4.3.4"},"reference-count":88,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:00:00Z","timestamp":1791504000000},"content-version":"vor","delay-in-days":86,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["24DIVSUP1267989"],"award-info":[{"award-number":["24DIVSUP1267989"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["20CDA35260116"],"award-info":[{"award-number":["20CDA35260116"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI155488"],"award-info":[{"award-number":["R01AI155488"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"DOI":"10.1186\/s12964-026-03066-w","type":"journal-article","created":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T03:35:17Z","timestamp":1784086517000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["TRIM47 catalyzes MAVS SUMOylation to safeguard chronic viral infections and tissue inflammation"],"prefix":"10.1186","volume":"24","author":[{"given":"Wenting","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junji","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurie J.","family":"Minze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian C.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,15]]},"reference":[{"key":"3066_CR1","unstructured":"Boldogh I, Albrecht T, Porter DD. Persistent viral infections. In: Baron S, editor. Medical Microbiology. 4th edition. Galveston (TX): University of Texas Medical Branch at Galveston; 1996."},{"key":"3066_CR2","doi-asserted-by":"publisher","first-page":"S24","DOI":"10.1016\/j.jaci.2009.07.016","volume":"125","author":"SE Turvey","year":"2010","unstructured":"Turvey SE, Broide DH. Innate immunity. J Allergy Clin Immunol. 2010;125:S24\u201332.","journal-title":"J Allergy Clin Immunol"},{"key":"3066_CR3","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/ni.3123","volume":"16","author":"A Iwasaki","year":"2015","unstructured":"Iwasaki A, Medzhitov R. Control of adaptive immunity by the innate immune system. Nat Immunol. 2015;16:343\u201353.","journal-title":"Nat Immunol"},{"key":"3066_CR4","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1056\/NEJM200008033430506","volume":"343","author":"R Medzhitov","year":"2000","unstructured":"Medzhitov R, Janeway C Jr. Innate immunity. N Engl J Med. 2000;343:338\u201344.","journal-title":"N Engl J Med"},{"key":"3066_CR5","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1007\/s00018-025-05864-w","volume":"82","author":"L Wang","year":"2025","unstructured":"Wang L, He D, Satoh-Takayama N, Zheng C, Xing J. Regulation of antiviral and antimicrobial innate immunity and immune evasion. Cell Mol Life Sci. 2025;82:326.","journal-title":"Cell Mol Life Sci"},{"key":"3066_CR6","doi-asserted-by":"publisher","first-page":"1358542","DOI":"10.3389\/fimmu.2023.1358542","volume":"14","author":"W Lu","year":"2023","unstructured":"Lu W, Wang L, Xing J, Editorial. Antiviral innate immune sensing, regulation, and viral immune evasion. Front Immunol. 2023;14:1358542.","journal-title":"Front Immunol"},{"key":"3066_CR7","doi-asserted-by":"publisher","first-page":"1341193","DOI":"10.3389\/fimmu.2023.1341193","volume":"14","author":"L Wang","year":"2023","unstructured":"Wang L, Xing J, Editorial. Community series in antiviral innate immune sensing, regulation, and viral immune evasion: II. Front Immunol. 2023;14:1341193.","journal-title":"Front Immunol"},{"key":"3066_CR8","doi-asserted-by":"publisher","first-page":"1233791","DOI":"10.3389\/fimmu.2023.1233791","volume":"14","author":"J Zhang","year":"2023","unstructured":"Zhang J, Xing J, Editorial. Plasticity and metabolic switching in adipose tissue macrophages. Front Immunol. 2023;14:1233791.","journal-title":"Front Immunol"},{"key":"3066_CR9","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/s41392-023-01452-1","volume":"8","author":"S Chen","year":"2023","unstructured":"Chen S, et al. Macrophages in immunoregulation and therapeutics. Signal Transduct Target Ther. 2023;8:207.","journal-title":"Signal Transduct Target Ther"},{"key":"3066_CR10","doi-asserted-by":"crossref","unstructured":"Ramasamy S, Subbian S. Critical Determinants of Cytokine Storm and Type I Interferon Response in COVID-19 Pathogenesis. Clin Microbiol Rev. 2021;34(3):e00299\u201320.","DOI":"10.1128\/CMR.00299-20"},{"key":"3066_CR11","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.smim.2015.07.002","volume":"27","author":"MP Motwani","year":"2015","unstructured":"Motwani MP, Gilroy DW. Macrophage development and polarization in chronic inflammation. Semin Immunol. 2015;27:257\u201366.","journal-title":"Semin Immunol"},{"key":"3066_CR12","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1038\/s41423-023-01039-4","volume":"20","author":"O Garcia-Nicolas","year":"2023","unstructured":"Garcia-Nicolas O, Godel A, Zimmer G, Summerfield A. Macrophage phagocytosis of SARS-CoV-2-infected cells mediates potent plasmacytoid dendritic cell activation. Cell Mol Immunol. 2023;20:835\u201349.","journal-title":"Cell Mol Immunol"},{"key":"3066_CR13","doi-asserted-by":"publisher","first-page":"5343","DOI":"10.1038\/s41467-023-41028-9","volume":"14","author":"QQ He","year":"2023","unstructured":"He QQ, et al. MAVS integrates glucose metabolism and RIG-I-like receptor signaling. Nat Commun. 2023;14:5343.","journal-title":"Nat Commun"},{"key":"3066_CR14","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1038\/cmi.2017.88","volume":"14","author":"CH Liu","year":"2017","unstructured":"Liu CH, Liu H, Ge B. Innate immunity in tuberculosis: host defense vs pathogen evasion. Cell Mol Immunol. 2017;14:963\u201375.","journal-title":"Cell Mol Immunol"},{"key":"3066_CR15","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/s41392-021-00687-0","volume":"6","author":"D Li","year":"2021","unstructured":"Li D, Wu M. Pattern recognition receptors in health and diseases. Signal Transduct Target Ther. 2021;6:291.","journal-title":"Signal Transduct Target Ther"},{"key":"3066_CR16","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.cell.2010.01.022","volume":"140","author":"O Takeuchi","year":"2010","unstructured":"Takeuchi O, Akira S. Pattern recognition receptors and inflammation. Cell. 2010;140:805\u201320.","journal-title":"Cell"},{"key":"3066_CR17","doi-asserted-by":"publisher","first-page":"1658579","DOI":"10.3389\/fimmu.2025.1658579","volume":"16","author":"P Nguyen","year":"2025","unstructured":"Nguyen P, Jacobs B, Mohanram A, Hammons C, Xing J. Tug of war: innate immunity and herpes simplex keratitis. Front Immunol. 2025;16:1658579.","journal-title":"Front Immunol"},{"key":"3066_CR18","doi-asserted-by":"publisher","first-page":"14590","DOI":"10.1073\/pnas.1110133108","volume":"108","author":"SM Horner","year":"2011","unstructured":"Horner SM, Liu HM, Park HS, Briley J, Gale M Jr. Mitochondrial-associated endoplasmic reticulum membranes (MAM) form innate immune synapses and are targeted by hepatitis C virus. Proc Natl Acad Sci U S A. 2011;108:14590\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3066_CR19","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/s41467-020-20316-8","volume":"12","author":"L Zhou","year":"2021","unstructured":"Zhou L, et al. Hepatitis B virus rigs the cellular metabolome to avoid innate immune recognition. Nat Commun. 2021;12:98.","journal-title":"Nat Commun"},{"key":"3066_CR20","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.cell.2005.08.012","volume":"122","author":"RB Seth","year":"2005","unstructured":"Seth RB, Sun L, Ea CK, Chen ZJ. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell. 2005;122:669\u201382.","journal-title":"Cell"},{"key":"3066_CR21","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/nature10429","volume":"478","author":"DL Burdette","year":"2011","unstructured":"Burdette DL, et al. STING is a direct innate immune sensor of cyclic di-GMP. Nature. 2011;478:515\u20138.","journal-title":"Nature"},{"key":"3066_CR22","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s13238-012-2063-0","volume":"4","author":"H Chen","year":"2013","unstructured":"Chen H, Jiang Z. The essential adaptors of innate immune signaling. Protein Cell. 2013;4:27\u201339.","journal-title":"Protein Cell"},{"key":"3066_CR23","doi-asserted-by":"publisher","first-page":"aaa2630","DOI":"10.1126\/science.aaa2630","volume":"347","author":"S Liu","year":"2015","unstructured":"Liu S, et al. Phosphorylation of innate immune adaptor proteins MAVS, STING, and TRIF induces IRF3 activation. Science. 2015;347:aaa2630.","journal-title":"Science"},{"key":"3066_CR24","doi-asserted-by":"publisher","first-page":"e00785","DOI":"10.7554\/eLife.00785","volume":"2","author":"S Liu","year":"2013","unstructured":"Liu S, et al. MAVS recruits multiple ubiquitin E3 ligases to activate antiviral signaling cascades. Elife. 2013;2:e00785.","journal-title":"Elife"},{"key":"3066_CR25","doi-asserted-by":"crossref","unstructured":"Yum S, Li M, Fang Y, Chen ZJ. TBK1 recruitment to STING activates both IRF3 and NF-kappaB that mediate immune defense against tumors and viral infections. Proc Natl Acad Sci U S A. 2021;118(14):e2100225118.","DOI":"10.1073\/pnas.2100225118"},{"key":"3066_CR26","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s00018-022-04332-z","volume":"79","author":"E Zhang","year":"2022","unstructured":"Zhang E, et al. Mechanisms involved in controlling RNA virus-induced intestinal inflammation. Cell Mol Life Sci. 2022;79:313.","journal-title":"Cell Mol Life Sci"},{"key":"3066_CR27","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.it.2017.05.005","volume":"38","author":"LM Snell","year":"2017","unstructured":"Snell LM, McGaha TL, Brooks DG. Type I Interferon in Chronic Virus Infection and Cancer. Trends Immunol. 2017;38:542\u201357.","journal-title":"Trends Immunol"},{"key":"3066_CR28","doi-asserted-by":"publisher","first-page":"101277","DOI":"10.1016\/j.smim.2019.05.001","volume":"43","author":"S Lukhele","year":"2019","unstructured":"Lukhele S, Boukhaled GM, Brooks DG. Type I interferon signaling, regulation and gene stimulation in chronic virus infection. Semin Immunol. 2019;43:101277.","journal-title":"Semin Immunol"},{"key":"3066_CR29","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/nri3787","volume":"15","author":"F McNab","year":"2015","unstructured":"McNab F, Mayer-Barber K, Sher A, Wack A. O\u2019Garra, A. Type I interferons in infectious disease. Nat Rev Immunol. 2015;15:87\u2013103.","journal-title":"Nat Rev Immunol"},{"key":"3066_CR30","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s41423-022-00962-2","volume":"20","author":"CG Hsu","year":"2023","unstructured":"Hsu CG, Li W, Sowden M, Chavez CL, Berk BC. Pnpt1 mediates NLRP3 inflammasome activation by MAVS and metabolic reprogramming in macrophages. Cell Mol Immunol. 2023;20:131\u201342.","journal-title":"Cell Mol Immunol"},{"key":"3066_CR31","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.cell.2013.02.054","volume":"153","author":"N Subramanian","year":"2013","unstructured":"Subramanian N, Natarajan K, Clatworthy MR, Wang Z, Germain RN. The adaptor MAVS promotes NLRP3 mitochondrial localization and inflammasome activation. Cell. 2013;153:348\u201361.","journal-title":"Cell"},{"key":"3066_CR32","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41421-023-00622-3","volume":"10","author":"S Liu","year":"2024","unstructured":"Liu S, et al. The E3 ubiquitin ligase MARCH2 protects against myocardial ischemia-reperfusion injury through inhibiting pyroptosis via negative regulation of PGAM5\/MAVS\/NLRP3 axis. Cell Discov. 2024;10:24.","journal-title":"Cell Discov"},{"key":"3066_CR33","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/nrd.2018.97","volume":"17","author":"MSJ Mangan","year":"2018","unstructured":"Mangan MSJ, et al. Targeting the NLRP3 inflammasome in inflammatory diseases. Nat Rev Drug Discov. 2018;17:688.","journal-title":"Nat Rev Drug Discov"},{"key":"3066_CR34","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/s41421-020-0167-x","volume":"6","author":"D Zheng","year":"2020","unstructured":"Zheng D, Liwinski T, Elinav E. Inflammasome activation and regulation: toward a better understanding of complex mechanisms. Cell Discov. 2020;6:36.","journal-title":"Cell Discov"},{"key":"3066_CR35","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1146\/annurev-immunol-031210-101405","volume":"29","author":"BK Davis","year":"2011","unstructured":"Davis BK, Wen H, Ting JP. The inflammasome NLRs in immunity, inflammation, and associated diseases. Annu Rev Immunol. 2011;29:707\u201335.","journal-title":"Annu Rev Immunol"},{"key":"3066_CR36","doi-asserted-by":"publisher","first-page":"5589","DOI":"10.1111\/bph.12876","volume":"171","author":"SM Krishnan","year":"2014","unstructured":"Krishnan SM, Sobey CG, Latz E, Mansell A, Drummond GR. IL-1beta and IL-18: inflammatory markers or mediators of hypertension? Br J Pharmacol. 2014;171:5589\u2013602.","journal-title":"Br J Pharmacol"},{"key":"3066_CR37","doi-asserted-by":"publisher","first-page":"1151185","DOI":"10.3389\/fimmu.2023.1151185","volume":"14","author":"X Zheng","year":"2023","unstructured":"Zheng X, Wan J, Tan G. The mechanisms of NLRP3 inflammasome\/pyroptosis activation and their role in diabetic retinopathy. Front Immunol. 2023;14:1151185.","journal-title":"Front Immunol"},{"key":"3066_CR38","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s43556-021-00043-2","volume":"2","author":"Q Yang","year":"2021","unstructured":"Yang Q, Zhao J, Chen D, Wang Y. E3 ubiquitin ligases: styles, structures and functions. Mol Biomed. 2021;2:23.","journal-title":"Mol Biomed"},{"key":"3066_CR39","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/cr.2016.39","volume":"26","author":"KN Swatek","year":"2016","unstructured":"Swatek KN, Komander D. Ubiquitin modifications. Cell Res. 2016;26:399\u2013422.","journal-title":"Cell Res"},{"key":"3066_CR40","doi-asserted-by":"publisher","first-page":"106276","DOI":"10.1016\/j.isci.2023.106276","volume":"26","author":"H Barbour","year":"2023","unstructured":"Barbour H, et al. An inventory of crosstalk between ubiquitination and other post-translational modifications in orchestrating cellular processes. iScience. 2023;26:106276.","journal-title":"iScience"},{"key":"3066_CR41","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1038\/onc.2010.462","volume":"30","author":"Y Chu","year":"2011","unstructured":"Chu Y, Yang X. SUMO E3 ligase activity of TRIM proteins. Oncogene. 2011;30:1108\u201316.","journal-title":"Oncogene"},{"key":"3066_CR42","doi-asserted-by":"publisher","first-page":"3481","DOI":"10.1038\/s41467-024-44745-x","volume":"15","author":"J Wang","year":"2024","unstructured":"Wang J, et al. Loss of TRIM29 mitigates viral myocarditis by attenuating PERK-driven ER stress response in male mice. Nat Commun. 2024;15:3481.","journal-title":"Nat Commun"},{"key":"3066_CR43","doi-asserted-by":"publisher","first-page":"R42","DOI":"10.1016\/j.cub.2018.11.026","volume":"29","author":"M Vunjak","year":"2019","unstructured":"Vunjak M, Versteeg GA. TRIM proteins. Curr Biol. 2019;29:R42\u20134.","journal-title":"Curr Biol"},{"key":"3066_CR44","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1038\/cr.2014.46","volume":"24","author":"Y Li","year":"2014","unstructured":"Li Y, et al. Structural insights into the TRIM family of ubiquitin E3 ligases. Cell Res. 2014;24:762\u20135.","journal-title":"Cell Res"},{"key":"3066_CR45","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1038\/nri2413","volume":"8","author":"K Ozato","year":"2008","unstructured":"Ozato K, Shin DM, Chang TH, Morse HC. 3rd. TRIM family proteins and their emerging roles in innate immunity. Nat Rev Immunol. 2008;8:849\u201360.","journal-title":"Nat Rev Immunol"},{"key":"3066_CR46","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1038\/onc.2014.68","volume":"34","author":"T Sato","year":"2015","unstructured":"Sato T, Takahashi H, Hatakeyama S, Iguchi A, Ariga T. The TRIM-FLMN protein TRIM45 directly interacts with RACK1 and negatively regulates PKC-mediated signaling pathway. Oncogene. 2015;34:1280\u201391.","journal-title":"Oncogene"},{"key":"3066_CR47","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12929-022-00840-z","volume":"29","author":"M Fang","year":"2022","unstructured":"Fang M, et al. TRIM18 is a critical regulator of viral myocarditis and organ inflammation. J Biomed Sci. 2022;29:55.","journal-title":"J Biomed Sci"},{"key":"3066_CR48","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1038\/ni.3580","volume":"17","author":"J Xing","year":"2016","unstructured":"Xing J, et al. Identification of a role for TRIM29 in the control of innate immunity in the respiratory tract. Nat Immunol. 2016;17:1373\u201380.","journal-title":"Nat Immunol"},{"key":"3066_CR49","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1038\/s41467-017-00101-w","volume":"8","author":"J Xing","year":"2017","unstructured":"Xing J, et al. TRIM29 promotes DNA virus infections by inhibiting innate immune response. Nat Commun. 2017;8:945.","journal-title":"Nat Commun"},{"key":"3066_CR50","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1038\/s41423-020-00564-w","volume":"18","author":"Z Gu","year":"2021","unstructured":"Gu Z, et al. The SUMOylation of TAB2 mediated by TRIM60 inhibits MAPK\/NF-kappaB activation and the innate immune response. Cell Mol Immunol. 2021;18:1981\u201394.","journal-title":"Cell Mol Immunol"},{"key":"3066_CR51","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s13046-019-1143-x","volume":"38","author":"Q Liang","year":"2019","unstructured":"Liang Q, et al. TRIM47 is up-regulated in colorectal cancer, promoting ubiquitination and degradation of SMAD4. J Exp Clin Cancer Res. 2019;38:159.","journal-title":"J Exp Clin Cancer Res"},{"key":"3066_CR52","doi-asserted-by":"crossref","unstructured":"Azuma K et al. TRIM47 activates NF-kappaB signaling via PKC-epsilon\/PKD3 stabilization and contributes to endocrine therapy resistance in breast cancer. Proc Natl Acad Sci U S A. 2021;118(35):e2100784118.","DOI":"10.1073\/pnas.2100784118"},{"key":"3066_CR53","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/s41392-022-00953-9","volume":"7","author":"Y Qian","year":"2022","unstructured":"Qian Y, et al. TRIM47 is a novel endothelial activation factor that aggravates lipopolysaccharide-induced acute lung injury in mice via K63-linked ubiquitination of TRAF2. Signal Transduct Target Ther. 2022;7:148.","journal-title":"Signal Transduct Target Ther"},{"key":"3066_CR54","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1002\/cbin.12186","volume":"48","author":"W Zhan","year":"2024","unstructured":"Zhan W, Zhang H, Su Y, Yin L. TRIM47 promotes HDM-induced bronchial epithelial pyroptosis by regulating NEMO ubiquitination to activate NF-kappaB\/NLRP3 signaling. Cell Biol Int. 2024;48:1138\u201347.","journal-title":"Cell Biol Int"},{"key":"3066_CR55","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.mucimm.2024.10.004","volume":"18","author":"J Wang","year":"2025","unstructured":"Wang J, et al. TRIM29 controls enteric RNA virus-induced intestinal inflammation by targeting NLRP6 and NLRP9b signaling pathways. Mucosal Immunol. 2025;18:135\u201350.","journal-title":"Mucosal Immunol"},{"key":"3066_CR56","doi-asserted-by":"publisher","first-page":"e49666","DOI":"10.15252\/embr.201949666","volume":"21","author":"A Zhang","year":"2020","unstructured":"Zhang A, et al. EphA2 phosphorylates NLRP3 and inhibits inflammasomes in airway epithelial cells. EMBO Rep. 2020;21:e49666.","journal-title":"EMBO Rep"},{"key":"3066_CR57","doi-asserted-by":"publisher","first-page":"109205","DOI":"10.1016\/j.celrep.2021.109205","volume":"35","author":"J Xing","year":"2021","unstructured":"Xing J, et al. DHX15 is required to control RNA virus-induced intestinal inflammation. Cell Rep. 2021;35:109205.","journal-title":"Cell Rep"},{"key":"3066_CR58","doi-asserted-by":"publisher","first-page":"2681","DOI":"10.1038\/s41467-021-23003-4","volume":"12","author":"J Xing","year":"2021","unstructured":"Xing J, et al. Identification of poly(ADP-ribose) polymerase 9 (PARP9) as a noncanonical sensor for RNA virus in dendritic cells. Nat Commun. 2021;12:2681.","journal-title":"Nat Commun"},{"key":"3066_CR59","doi-asserted-by":"crossref","unstructured":"Xiao X et al. Apex1 safeguards genomic stability to ensure a cytopathic T cell fate in autoimmune disease models. J Clin Invest. 2024;135(4):e183671.","DOI":"10.1172\/JCI183671"},{"key":"3066_CR60","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.ajpath.2017.09.014","volume":"188","author":"HK Ashar","year":"2018","unstructured":"Ashar HK, et al. The Role of Extracellular Histones in Influenza Virus Pathogenesis. Am J Pathol. 2018;188:135\u201348.","journal-title":"Am J Pathol"},{"key":"3066_CR61","doi-asserted-by":"publisher","first-page":"183","DOI":"10.4049\/jimmunol.1701569","volume":"201","author":"J Xing","year":"2018","unstructured":"Xing J, Zhang A, Minze LJ, Li XC, Zhang Z. TRIM29 Negatively Regulates the Type I IFN Production in Response to RNA Virus. J Immunol. 2018;201:183\u201392.","journal-title":"J Immunol"},{"key":"3066_CR62","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/ni.3641","volume":"18","author":"B Liu","year":"2017","unstructured":"Liu B, et al. The ubiquitin E3 ligase TRIM31 promotes aggregation and activation of the signaling adaptor MAVS through Lys63-linked polyubiquitination. Nat Immunol. 2017;18:214\u201324.","journal-title":"Nat Immunol"},{"key":"3066_CR63","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.cytogfr.2011.10.001","volume":"22","author":"G Lopez-Castejon","year":"2011","unstructured":"Lopez-Castejon G, Brough D. Understanding the mechanism of IL-1beta secretion. Cytokine Growth Factor Rev. 2011;22:189\u201395.","journal-title":"Cytokine Growth Factor Rev"},{"key":"3066_CR64","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1038\/s41423-021-00670-3","volume":"18","author":"S Paik","year":"2021","unstructured":"Paik S, Kim JK, Silwal P, Sasakawa C, Jo EK. An update on the regulatory mechanisms of NLRP3 inflammasome activation. Cell Mol Immunol. 2021;18:1141\u201360.","journal-title":"Cell Mol Immunol"},{"key":"3066_CR65","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.coviro.2017.01.003","volume":"23","author":"MK McCarthy","year":"2017","unstructured":"McCarthy MK, Morrison TE. Persistent RNA virus infections: do PAMPS drive chronic disease? Curr Opin Virol. 2017;23:8\u201315.","journal-title":"Curr Opin Virol"},{"key":"3066_CR66","first-page":"1","volume":"91","author":"BN Fields","year":"1981","unstructured":"Fields BN. Genetics of Reovirus. Curr Top Microbiol Immunol. 1981;91:1\u201324.","journal-title":"Curr Top Microbiol Immunol"},{"key":"3066_CR67","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.cell.2011.06.041","volume":"146","author":"F Hou","year":"2011","unstructured":"Hou F, et al. MAVS forms functional prion-like aggregates to activate and propagate antiviral innate immune response. Cell. 2011;146:448\u201361.","journal-title":"Cell"},{"key":"3066_CR68","doi-asserted-by":"publisher","first-page":"eabf2846","DOI":"10.1126\/sciimmunol.abf2846","volume":"7","author":"DP Simmons","year":"2022","unstructured":"Simmons DP, et al. SLAMF7 engagement superactivates macrophages in acute and chronic inflammation. Sci Immunol. 2022;7:eabf2846.","journal-title":"Sci Immunol"},{"key":"3066_CR69","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1084\/jem.20151764","volume":"213","author":"D Langlais","year":"2016","unstructured":"Langlais D, Barreiro LB, Gros P. The macrophage IRF8\/IRF1 regulome is required for protection against infections and is associated with chronic inflammation. J Exp Med. 2016;213:585\u2013603.","journal-title":"J Exp Med"},{"key":"3066_CR70","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1146\/annurev-physiol-022516-034348","volume":"79","author":"K Hamidzadeh","year":"2017","unstructured":"Hamidzadeh K, Christensen SM, Dalby E, Chandrasekaran P, Mosser DM. Macrophages and the Recovery from Acute and Chronic Inflammation. Annu Rev Physiol. 2017;79:567\u201392.","journal-title":"Annu Rev Physiol"},{"key":"3066_CR71","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1186\/s13075-016-1102-2","volume":"18","author":"J Lubbers","year":"2016","unstructured":"Lubbers J, et al. Changes in peripheral blood lymphocyte subsets during arthritis development in arthralgia patients. Arthritis Res Ther. 2016;18:205.","journal-title":"Arthritis Res Ther"},{"key":"3066_CR72","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1093\/rheumatology\/keh112","volume":"43","author":"AL Hepburn","year":"2004","unstructured":"Hepburn AL, Mason JC, Davies KA. Expression of Fcgamma and complement receptors on peripheral blood monocytes in systemic lupus erythematosus and rheumatoid arthritis. Rheumatology (Oxford). 2004;43:547\u201354.","journal-title":"Rheumatology (Oxford)"},{"key":"3066_CR73","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1093\/rheumatology\/keg174","volume":"42","author":"S Wijngaarden","year":"2003","unstructured":"Wijngaarden S, van Roon JA, Bijlsma JW, van de Winkel JG, Lafeber FP. Fcgamma receptor expression levels on monocytes are elevated in rheumatoid arthritis patients with high erythrocyte sedimentation rate who do not use anti-rheumatic drugs. Rheumatology (Oxford). 2003;42:681\u20138.","journal-title":"Rheumatology (Oxford)"},{"key":"3066_CR74","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.cell.2011.04.005","volume":"145","author":"KJ Moore","year":"2011","unstructured":"Moore KJ, Tabas I. Macrophages in the pathogenesis of atherosclerosis. Cell. 2011;145:341\u201355.","journal-title":"Cell"},{"key":"3066_CR75","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1038\/nri2415","volume":"8","author":"C Weber","year":"2008","unstructured":"Weber C, Zernecke A, Libby P. The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models. Nat Rev Immunol. 2008;8:802\u201315.","journal-title":"Nat Rev Immunol"},{"key":"3066_CR76","doi-asserted-by":"crossref","unstructured":"Britt RD Jr., Ruwanpathirana A, Ford ML, Lewis BW. Macrophages Orchestrate Airway Inflammation, Remodeling, and Resolution in Asthma. Int J Mol Sci. 2023;24(13):10451.","DOI":"10.3390\/ijms241310451"},{"key":"3066_CR77","doi-asserted-by":"publisher","first-page":"3649","DOI":"10.1038\/s41467-019-11250-5","volume":"10","author":"AEL Stone","year":"2019","unstructured":"Stone AEL, Green R, Wilkins C, Hemann EA, Gale M. Jr. RIG-I-like receptors direct inflammatory macrophage polarization against West Nile virus infection. Nat Commun. 2019;10:3649.","journal-title":"Nat Commun"},{"key":"3066_CR78","doi-asserted-by":"publisher","first-page":"17963","DOI":"10.1073\/pnas.1312571110","volume":"110","author":"T Ichinohe","year":"2013","unstructured":"Ichinohe T, Yamazaki T, Koshiba T, Yanagi Y. Mitochondrial protein mitofusin 2 is required for NLRP3 inflammasome activation after RNA virus infection. Proc Natl Acad Sci U S A. 2013;110:17963\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3066_CR79","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.4049\/jimmunol.159.5.2452","volume":"159","author":"M Labow","year":"1997","unstructured":"Labow M, et al. Absence of IL-1 signaling and reduced inflammatory response in IL-1 type I receptor-deficient mice. J Immunol. 1997;159:2452\u201361.","journal-title":"J Immunol"},{"key":"3066_CR80","first-page":"S1","volume":"20","author":"CA Dinarello","year":"2002","unstructured":"Dinarello CA. The IL-1 family and inflammatory diseases. Clin Exp Rheumatol. 2002;20:S1\u201313.","journal-title":"Clin Exp Rheumatol"},{"key":"3066_CR81","doi-asserted-by":"publisher","first-page":"25900","DOI":"10.1074\/jbc.M707692200","volume":"283","author":"CM Cahill","year":"2008","unstructured":"Cahill CM, Rogers JT. Interleukin (IL) 1beta induction of IL-6 is mediated by a novel phosphatidylinositol 3-kinase-dependent AKT\/IkappaB kinase alpha pathway targeting activator protein-1. J Biol Chem. 2008;283:25900\u201312.","journal-title":"J Biol Chem"},{"key":"3066_CR82","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1189\/jlb.1012543","volume":"93","author":"KH Mills","year":"2013","unstructured":"Mills KH, Dungan LS, Jones SA, Harris J. The role of inflammasome-derived IL-1 in driving IL-17 responses. J Leukoc Biol. 2013;93:489\u201397.","journal-title":"J Leukoc Biol"},{"key":"3066_CR83","doi-asserted-by":"publisher","first-page":"591713","DOI":"10.3389\/fimmu.2020.591713","volume":"11","author":"Y Sasaki","year":"2020","unstructured":"Sasaki Y, Otsuka K, Arimochi H, Tsukumo SI, Yasutomo K. Distinct Roles of IL-1beta and IL-18 in NLRC4-Induced Autoinflammation. Front Immunol. 2020;11:591713.","journal-title":"Front Immunol"},{"key":"3066_CR84","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/j.celrep.2016.12.069","volume":"18","author":"M Dutta","year":"2017","unstructured":"Dutta M, et al. A Systems Approach Reveals MAVS Signaling in Myeloid Cells as Critical for Resistance to Ebola Virus in Murine Models of Infection. Cell Rep. 2017;18:816\u201329.","journal-title":"Cell Rep"},{"key":"3066_CR85","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/1741-7007-10-44","volume":"10","author":"C Castanier","year":"2012","unstructured":"Castanier C, et al. MAVS ubiquitination by the E3 ligase TRIM25 and degradation by the proteasome is involved in type I interferon production after activation of the antiviral RIG-I-like receptors. BMC Biol. 2012;10:44.","journal-title":"BMC Biol"},{"key":"3066_CR86","doi-asserted-by":"crossref","unstructured":"Xue B et al. TRIM21 Promotes Innate Immune Response to RNA Viral Infection through Lys27-Linked Polyubiquitination of MAVS. J Virol. 2018;92(14):e00321\u201318.","DOI":"10.1128\/JVI.00321-18"},{"key":"3066_CR87","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.3389\/fimmu.2018.02479","volume":"9","author":"H Liu","year":"2018","unstructured":"Liu H, Li M, Song Y, Xu W. TRIM21 Restricts Coxsackievirus B3 Replication, Cardiac and Pancreatic Injury via Interacting With MAVS and Positively Regulating IRF3-Mediated Type-I Interferon Production. Front Immunol. 2018;9:2479.","journal-title":"Front Immunol"},{"key":"3066_CR88","doi-asserted-by":"publisher","first-page":"6787","DOI":"10.1038\/s41467-024-51199-8","volume":"15","author":"F Chen","year":"2024","unstructured":"Chen F, et al. Trim47 prevents hematopoietic stem cell exhaustion during stress by regulating MAVS-mediated innate immune pathway. Nat Commun. 2024;15:6787.","journal-title":"Nat Commun"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12964-026-03066-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-026-03066-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-026-03066-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T01:03:03Z","timestamp":1791507783000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12964-026-03066-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,15]]},"references-count":88,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3066"],"URL":"https:\/\/doi.org\/10.1186\/s12964-026-03066-w","relation":{},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,15]]},"assertion":[{"value":"16 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal protocols were performed according to the guidelines and approved by the Institutional Animal Care and Use Committee of Houston Methodist.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"539"}}